HUP1300496A2 - Stable pharmaceutical composition - Google Patents

Stable pharmaceutical composition

Info

Publication number
HUP1300496A2
HUP1300496A2 HU1300496A HUP1300496A HUP1300496A2 HU P1300496 A2 HUP1300496 A2 HU P1300496A2 HU 1300496 A HU1300496 A HU 1300496A HU P1300496 A HUP1300496 A HU P1300496A HU P1300496 A2 HUP1300496 A2 HU P1300496A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
stable pharmaceutical
stable
composition
pharmaceutical
Prior art date
Application number
HU1300496A
Other languages
Hungarian (hu)
Inventor
Molnar Eva Gutine
Zsigmond Zsolt Dr
Zoltanne Toth
Orban Adam Dr
Original Assignee
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag filed Critical Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag
Priority to HU1300496A priority Critical patent/HUP1300496A2/en
Priority to PCT/HU2014/000072 priority patent/WO2015022560A1/en
Priority to EA201690395A priority patent/EA033291B1/en
Priority to PCT/HU2014/000071 priority patent/WO2015022559A1/en
Priority to HU1600414A priority patent/HU231052B1/en
Publication of HUP1300496A2 publication Critical patent/HUP1300496A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
HU1300496A 2013-08-16 2013-08-16 Stable pharmaceutical composition HUP1300496A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HU1300496A HUP1300496A2 (en) 2013-08-16 2013-08-16 Stable pharmaceutical composition
PCT/HU2014/000072 WO2015022560A1 (en) 2013-08-16 2014-08-15 Stable pharmaceutical composition containing bisoprolol and ramipril
EA201690395A EA033291B1 (en) 2013-08-16 2014-08-15 Dosage unit comprising ramipril and bisoprolol hemifumarate, process for the preparation thereof and method of treating hypertension
PCT/HU2014/000071 WO2015022559A1 (en) 2013-08-16 2014-08-15 Pharmaceutical composition containing rosuvastatin and ramipril
HU1600414A HU231052B1 (en) 2013-08-16 2014-08-15 Stable pharmaceutical composition containing bisoprolol and ramipril

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1300496A HUP1300496A2 (en) 2013-08-16 2013-08-16 Stable pharmaceutical composition

Publications (1)

Publication Number Publication Date
HUP1300496A2 true HUP1300496A2 (en) 2015-03-02

Family

ID=89991232

Family Applications (2)

Application Number Title Priority Date Filing Date
HU1300496A HUP1300496A2 (en) 2013-08-16 2013-08-16 Stable pharmaceutical composition
HU1600414A HU231052B1 (en) 2013-08-16 2014-08-15 Stable pharmaceutical composition containing bisoprolol and ramipril

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU1600414A HU231052B1 (en) 2013-08-16 2014-08-15 Stable pharmaceutical composition containing bisoprolol and ramipril

Country Status (3)

Country Link
EA (1) EA033291B1 (en)
HU (2) HUP1300496A2 (en)
WO (2) WO2015022559A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3501502A1 (en) * 2017-12-20 2019-06-26 Midas Pharma GmbH Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
WO2021160700A1 (en) 2020-02-10 2021-08-19 Adamed Pharma S.A. Composition comprising ramipril and indapamide
CN115068434B (en) * 2022-08-03 2023-05-09 昆山龙灯瑞迪制药有限公司 Preparation method of ramipril tablet

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050800B2 (en) 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3226768A1 (en) 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt DERIVATIVES OF CIS, ENDO-2-AZABICYCLO- (3.3.0) -OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF
DE3739690A1 (en) 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
US20030215526A1 (en) 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
CA2483099A1 (en) * 2002-05-03 2003-11-13 Hexal Ag Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
PL1635792T3 (en) 2003-06-26 2009-08-31 Teva Pharmaceutical Industries Ltd Stable pharmaceutical compositions of 2-aza-bicyclo¬3.3.0 -octane-3-carboxylic acid derivatives
US20060188568A1 (en) 2003-10-30 2006-08-24 Lupin Limited Stable formulations of ace inhibitors and methods for preparation thereof
GB2394660A (en) 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
US20080234353A1 (en) 2004-03-24 2008-09-25 Reynir Eyjolfsson Formulations of Ramipril
EP1817007A2 (en) 2004-11-05 2007-08-15 King Pharmaceuticals Research and Development Inc. Stabilized individually coated ramipril particles, compositions and methods
CA2628955A1 (en) * 2005-11-07 2007-05-18 Edward S. Wilson Compositions of stabilized ramipril in combination with another active agent
CN100374462C (en) 2005-11-21 2008-03-12 大连帝恩生物工程有限公司 Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use
US20070232680A1 (en) 2006-04-04 2007-10-04 Vijayabhaskar Bolugoddu Preparation of ramipril and stable pharmaceutical compositions
MX2008013374A (en) 2006-04-19 2008-11-12 Teva Pharma Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane -3-carboxylic acid derivatives.
WO2008000040A1 (en) 2006-06-30 2008-01-03 Alphapharm Pty Ltd A stabilised composition comprising ace inhibitors
WO2008021875A2 (en) 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Pharmaceutical tablets containing a plurality of active segments
WO2008065485A2 (en) 2006-10-19 2008-06-05 Torrent Pharmaceuticals Limited Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor
US9095519B2 (en) 2007-02-09 2015-08-04 Alphapharm Pty Ltd Dosage form containing two or more active pharmaceutical ingredients in different physical forms
WO2008132756A1 (en) 2007-05-01 2008-11-06 Lupin Limited Stable pharmaceutical compositions of ramipril
HU230877B1 (en) 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stable pharmaceutical combination
EP2272874A1 (en) 2009-07-10 2011-01-12 CSL Behring GmbH Role of PLD1 in thrombus formation and integrin alpha IIb beta 3 activation
CN101612403A (en) 2009-08-13 2009-12-30 王丽燕 The pharmaceutical composition that contains calcium antagonist, ACE inhibitor and statins
UA113977C2 (en) 2012-02-17 2017-04-10 PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY

Also Published As

Publication number Publication date
WO2015022560A8 (en) 2015-05-14
HU231052B1 (en) 2020-02-28
HUP1600414A2 (en) 2016-09-28
WO2015022559A1 (en) 2015-02-19
EA201690395A1 (en) 2016-07-29
WO2015022560A1 (en) 2015-02-19
EA033291B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
HUE046964T2 (en) Combined pharmaceutical composition
PL2943181T3 (en) Pharmaceutical compositions
PL3043778T3 (en) Pharmaceutical compositions containing refametinib
HK1215191A1 (en) Low dose pharmaceutical composition
HK1213182A1 (en) Pharmaceutical composition for external application
ZA201408333B (en) Pharmaceutical compositions
EP2990038A4 (en) Solid pharmaceutical composition
SG11201601477VA (en) Pharmaceutical composition
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
GB201320932D0 (en) Topical pharmaceutical composition
IL242704B (en) Pharmaceutical preparation
HUP1300496A2 (en) Stable pharmaceutical composition
HRP20171888T1 (en) Pharmaceutical compositions
HK1220143A1 (en) Pharmaceutical composition
GB201304699D0 (en) Pharmaceutical compositions
EP2992890A4 (en) Pharmaceutical composition
IL244316A0 (en) Novel drug formulation
GB201321497D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition
GB201312851D0 (en) Pharmaceutical compositions
AU2013903813A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal